Blog Posts

Daniel Nadal: Innovation in Cancer Diagnostics from India Signals a Global Shift in Early Detection

Daniel Nadal/LinkedIn

Jun 30, 2025, 00:00

Daniel Nadal: Innovation in Cancer Diagnostics from India Signals a Global Shift in Early Detection

Daniel Nadal, President at CLINsearch specializing in Life Sciences and Clinical Trials, shared a post on LinkedIn:

“Innovation in Cancer Diagnostics from India Signals a Global Shift in Early Detection.

As we continue to deepen our understanding of cancer, one truth remains clear early detection is one of the most effective ways to treat cancer and save lives. That is why, when I came across this exciting news from India, I felt compelled to share it.

Renjith Vijayakumar Selvarani. Ph.D, Founder, Chairman, and Chief Scientific and Technology Officer at OLUSIUM, recently introduced a groundbreaking development in multi-cancer diagnostics that could reshape the future of oncology.

OLUSIUM, an Indian-based startup, is developing a highly accurate, real-time, label-free, and cost-effective cancer detection platform. It is designed to identify asymptomatic cancers at their earliest stages and deliver digital pathology insights in real time, without the need for traditional labeling or markers. This innovation could significantly lower costs and broaden access to life-saving diagnostics.

This platform offers several promising advantages:

Faster patient turnaround with immediate results,

No labels or markers required,

Lower cost per test, increasing accessibility,

Early detection, when treatment is most effective.

Preliminary pilot studies and early multicentric validation have shown highly encouraging outcomes, making this a technology to watch very closely.

I am genuinely excited about this development and eager to learn more. How does it work? What types of cancers can it detect? What is the projected cost per test? When might it become available to the public? These are questions I hope to explore further, because breakthroughs like this have the potential to make early cancer detection more accessible and impactful around the world.

This is a powerful reminder that innovation knows no boundaries, and I cannot wait to see what comes next. Let me know what you guys think in the comment section down below!

Source: OncoDaily.”